Alan Ho, MD, PhD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alan Ho, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:22 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06891560 · A Study of Enfortumab Vedotin in People With Adenoid Cystic CarcinomaMemorial Sloan Kettering Cancer Center · recruiting · Adenoid Cystic Carcinoma · principal investigator
- Ph2NCT06007924 · A Study of Avutometinib and Defactinib in People With Thyroid CancerMemorial Sloan Kettering Cancer Center · recruiting · Thyroid Cancer · principal investigator
- Ph2NCT04209660 · Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland CancersMemorial Sloan Kettering Cancer Center · active not recruiting · Adenoid Cystic Carcinoma, Salivary Gland Cancer · principal investigator
- Early Ph1NCT03215095 · RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid CancersMemorial Sloan Kettering Cancer Center · active not recruiting · Thyroid Cancer · principal investigator
- Ph2NCT03172624 · Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland CancerMemorial Sloan Kettering Cancer Center · completed · Salivary Gland Cancer · principal investigator
- Ph2NCT02780310 · Testing Lenvatinib in Patients With Adenoid Cystic CarcinomaMemorial Sloan Kettering Cancer Center · active not recruiting · Adenoid Cystic Carcinoma · principal investigator
- Ph2NCT02098538 · Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic CarcinomaMemorial Sloan Kettering Cancer Center · completed · Adenoid Cystic Carcinoma · principal investigator
- Ph2NCT01183065 · Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)Memorial Sloan Kettering Cancer Center · completed · Head and Neck Cancer · principal investigator
- N/ANCT00970359 · Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244Memorial Sloan Kettering Cancer Center · completed · Thyroid Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.